Skip to content

Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia

Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia: a Multicenter Study in the Italian Outbreak

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04370275
Acronym
POCUSars-CoV-2
Enrollment
235
Registered
2020-04-30
Start date
2020-04-23
Completion date
2020-05-31
Last updated
2020-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Pneumonia, Viral

Keywords

Covid-19, Lung Ultrasound, POCUS

Brief summary

Is Lung Ultrasound really useful in diagnosing COVID19? What can be the usefulness of the Lung Ultrasound in the COVID19 epidemic? In the current state of the art, Sensitivity, Specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) of Lung Ultrasound in the diagnosis of COVID-19 are not yet known. Alveolar-interstitial lung diseases such as viral pneumonia and ARDS seems to have a specific ultrasound pattern that distinguishes them from bacterial pneumonia, preferentially represented by B lines, morphological irregularity of the pleural line, and small subpleural consolidations, but they could share these patterns with other pathologies, reducing specificity. In Italy, the Lung Ultrasound represents a consolidated method for the evaluation and management of all patients who come to the ER, and what we are sure of is its high sensitivity in identifying pathological patterns. Our preliminary data suggest that Lung Ultrasound is highly reliable not to include but to exclude the diagnosis of COVID-19 in patients with respiratory symptoms.

Detailed description

One of the first scientific papers published on the COVID-19 epidemic in China showed that patients still asymptomatic or paucisymptomatic, positive for SARS-CoV-2 on the RT-PCR test, presented chest CT images referring to parenchymal infiltrate with a prevalent appearance at ground-glass compatible with initial COVID-19 pneumonia. An ongoing study anticipates that the sensitivity of chest CT is higher than that of the RT-PCR molecular test for SARS-CoV-2 (performed on the pharyngeal swab or sputum) (50 out of 51, 98%, 95% CI: 90% -100% vs 36 out of 51, 71%, IC95%: 56% -83%) in the early diagnosis of COVID-19. Recent work seems to shows that Lung Ultrasound is effective in the clinical evaluation and diagnosis of COVID-19 pneumonia. In a previous study, in addition, sensitivity and specificity of the Lung Ultrasound in the early diagnosis of H1N1 flu pneumonia was 94.1% (32 out of 34) and 84.8% respectively (28 out of 33), with a positive predictive value of 86.5% (32 out of 37) and a negative predictive value of 93.3% (28 out of 30). The concordance between the lung ultrasound findings and the lung lesions found on CT has recently been demonstrated (lobe-specific concordance equal to 87%; lung-specific concordance equal to 92.5 % for the right lung and 83.6% for the left lung). These data suggest to better explore the diagnostic accuracy of the Lung Ultrasound in SARS-CoV-2 infection.

Interventions

None listed

Sponsors

Ospedale di Latisana
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Fever and/or * Cough and/or * Dyspnoea

Exclusion criteria

* No one

Design outcomes

Primary

MeasureTime frameDescription
Negative Predictive Value of Lung Ultrasound in the diagnosis of COVID-1930 daysLung Ultrasound accuracy in rule-out of patients with respiratory symptoms (fever and / or cough and / or dyspnoea) during the SARS-CoV-2 epidemic compared to nasopharyngeal swab and a composite reference standards

Secondary

MeasureTime frameDescription
Positive Predictive Value of Lung Ultrasound in the diagnosis of COVID-1930 daysLung Ultrasound accuracy in rule-in of patients with respiratory symptoms (fever and / or cough and / or dyspnoea) during the SARS-CoV-2 epidemic compared to nasopharyngeal swab and a composite reference standards
Sensitivity and Specificity of Lung Ultrasound in the diagnosis of COVID-1930 days

Countries

Italy

Contacts

Primary ContactCarmine C Di Gioia, MD
crisdigioia@yahoo.it+39 349 381 2503
Backup ContactDaniele Orso, MD
sd7782.do@gmail.com+39 329 016 2763

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026